According to Jazz Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 60,979,000. At the end of 2025 the company had 60,979,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2025 | 60.97 M | 0.73% |
2024 | 60.53 M | -3.26% |
2023 | 62.57 M | -0.75% |
2022 | 63.05 M | 2.52% |
2021 | 61.5 M | 9.95% |
2020 | 55.93 M | -0.86% |
2019 | 56.41 M | -4.9% |
2018 | 59.32 M | -1.1% |
2017 | 59.98 M | 0.08% |
2016 | 59.93 M | -2.54% |
2015 | 61.49 M | 1.46% |
2014 | 60.6 M | 4.1% |
2013 | 58.21 M | 0.89% |
2012 | 57.7 M | 37.3% |
2011 | 42.02 M | 7.86% |
2010 | 38.96 M | 26.12% |
2009 | 30.89 M | 14.45% |
2008 | 26.99 M | 14.04% |
2007 | 23.67 M | 75.78% |
2006 | 13.46 M | 0% |
2005 | 13.46 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Endo International
ENDPQ | 235,220,000 | 285.74% | ๐ฎ๐ช Ireland |
![]() AmerisourceBergen
ABC | 202,316,000 | 231.78% | ๐บ๐ธ USA |
![]() Novartis NVS | 1,968,000,000 | 3,127.34% | ๐จ๐ญ Switzerland |
![]() Teva Pharmaceutical Industries TEVA | 1,138,000,000 | 1,766.22% | ๐ฎ๐ฑ Israel |